RNA Therapy

Following a surge in activity triggered by the success of RNA vaccines for SARS-CoV-2, RNA therapies have undergone a huge wave of innovation and investment. With the ability to target previously undruggable pathways, as well as recent improvements in delivery mechanisms, nucleic acid modifications and modality types, RNA therapies promise to improve the patient outcomes for a wide range of diseases.

From exclusive industry dedicated conferences, RNA-specific clinical trial and drug data and year-round knowledge sharing and problem-solving expert networks, we provide a diverse set of opportunities to stay up to date with scientific advancements, solve shared challenges and gain the clarity of insight you need to accelerate the delivery of RNA therapies and vaccines to patients faster.